<DOC>
	<DOCNO>NCT00210288</DOCNO>
	<brief_summary>The purpose study ass immune response produce two dos SC599 vaccine compare placebo .</brief_summary>
	<brief_title>Healthy Adult Volunteer Study Two Doses Shigella Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Dysentery , Bacillary</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Adult volunteer age 18 50 Signed Informed Consent form follow detailed write explanation participation protocol Volunteers good health determine medical history , physical examination clinical judgement Volunteers available `` normally reside within M25 '' ( England ) Paris Paris suburb ( France ) leave England France duration study Women agree pregnancy test immediately immunisation use effective contraception study period Volunteers eligible free NHI treatment ( England ) , volunteer cover social security ( France ) Individuals hypersensitivity component vaccine use study . Individuals hypersensitivity ciprofloxacin Individuals find HIV HCV antibody positive Hepatitis B surface antigen positive time initial screening Individuals find HLAB27 tissue type time initial screening Individuals know suspected history gastrointestinal disease abnormality Concomitant therapy antibiotic , iron , zinc , H2receptor antagonists proton pump inhibitor Individuals receive vaccine Shigella proven suspect shigellosis ( bloody diarrhoea fever ) within 6 month prior study entry Individuals significant level immunity Shigella detect screen visit ( define serum ELISA antiLPS IgG antibody titre great 3 S.D . mean background activity bank healthy human serum ) A Clinically significant amount protein haemoglobin urine sample screen visit A Clinically significant abnormality haematological biochemical assay ( abnormal value define range quote centre ) screen visit A positive Shigella stool culture screen visit Individuals know impairment immune function receive immunosuppressive therapy ( include systemic corticosteroid ) . Inhaled topical steroid preparation noninclusion criterion Individuals acute infection ( include fever &gt; 37.5Â°C oral temperature ) time immunisation chronic disease Women capable become pregnant agree pregnancy test immunisation , agree take effective contraception study period Breastfeeding woman Individuals current problem substance abuse history substance abuse opinion investigator , might interfere participation study Individuals condition , opinion investigator , might interfere evaluation study objectives Individuals receive investigational product within 30 day prior entry Individuals read , speak fluent French English accord investigational site set Individuals plan leave England France prior end study period likely complete study Individuals person live opinion investigator may risk disease expose vaccine strain whose occupation may bring contact person risk disease food handler occupation Individuals close household contact child young 5 year person immunodeficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Healthy Volunteer</keyword>
	<keyword>Shigella</keyword>
	<keyword>Oral Vaccine</keyword>
	<keyword>Double Blind</keyword>
	<keyword>Placebo</keyword>
	<keyword>Immunogenicity</keyword>
	<keyword>Safety</keyword>
</DOC>